Skip to main content
Erschienen in: Medical Molecular Morphology 4/2016

28.03.2015 | Case Report

Breast carcinoma with a predominant duct-replacing component and chondroid matrix production

verfasst von: Shogo Tajima, Kenji Koda

Erschienen in: Medical Molecular Morphology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Breast carcinomas that produce chondroid matrix are extremely rare. If the carcinoma is invasive, it is classified as a matrix-producing carcinoma (MPC). Herein, we present a case of a breast carcinoma, which showed duct-replacing growth with chondroid matrix production. A 63-year-old woman underwent fine needle aspiration cytology for suspected malignancy, based on radiological findings. Cellular components showed sufficient atypia to allow a diagnosis of malignancy. A partial mastectomy was performed, and no mass-forming lesion was apparent in the surgically resected specimen. Histopathological examination showed that the carcinoma produced chondroid matrix and grew replacing ducts, which were associated with a small amount of an obvious invasive component without matrix production. Some parts of the duct-replacing component might take the form of expansile invasion due to the absence of residual duct-lining myoepithelial cells; it is difficult to decide whether the duct-replacing component is invasive or not. However, regarding a few tumor nests, they would be recognized as MPC-like intraductal components because of the focal presence of myoepithelial cells around them. Hence, this carcinoma could not be definitely diagnosed as a MPC, even though we believe they are closely related. This is the first reported case of a breast carcinoma displaying duct-replacing growth with chondroid matrix production.
Literatur
3.
Zurück zum Zitat Wargotz ES, Norris HJ (1989) Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol 20(7):628–635CrossRefPubMed Wargotz ES, Norris HJ (1989) Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol 20(7):628–635CrossRefPubMed
4.
Zurück zum Zitat Reis-Filho JS, Lakhani SR, Gobbi H, Sneige N (2012) Metaplastic carcinoma. In: Lakhani SR, Iore E, Schnitt SJ, Tan PH, van de Vijver MJ (eds) WHO classification of tumours of the breast, 4th edn. IARC Press, Lyon, pp 48–52 Reis-Filho JS, Lakhani SR, Gobbi H, Sneige N (2012) Metaplastic carcinoma. In: Lakhani SR, Iore E, Schnitt SJ, Tan PH, van de Vijver MJ (eds) WHO classification of tumours of the breast, 4th edn. IARC Press, Lyon, pp 48–52
5.
Zurück zum Zitat Huvos AG, Lucas JC Jr, Foote FW Jr (1973) Metaplastic breast carcinoma. Rare form of mammary cancer. N Y State J Med 73(9):1078–1082PubMed Huvos AG, Lucas JC Jr, Foote FW Jr (1973) Metaplastic breast carcinoma. Rare form of mammary cancer. N Y State J Med 73(9):1078–1082PubMed
7.
8.
Zurück zum Zitat Lien HC, Hsiao YH, Lin YS, Yao YT, Juan HF, Kuo WH, Hung MC, Chang KJ, Hsieh FJ (2007) Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Oncogene 26(57):7859–7871. doi:10.1038/sj.onc.1210593 CrossRefPubMed Lien HC, Hsiao YH, Lin YS, Yao YT, Juan HF, Kuo WH, Hung MC, Chang KJ, Hsieh FJ (2007) Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Oncogene 26(57):7859–7871. doi:10.​1038/​sj.​onc.​1210593 CrossRefPubMed
11.
Zurück zum Zitat Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N (2008) Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Am J Surg Pathol 32(4):544–552. doi:10.1097/PAS.0b013e31815a87e2 CrossRefPubMed Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N (2008) Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Am J Surg Pathol 32(4):544–552. doi:10.​1097/​PAS.​0b013e31815a87e2​ CrossRefPubMed
12.
Zurück zum Zitat Zhong F, Bi R, Yu B, Cheng Y, Xu X, Shui R, Yang W (2014) Carcinoma arising in microglandular adenosis of the breast: triple negative phenotype with variable morphology. Int J Clin Exp Pathol 7(9):6149–6156PubMedPubMedCentral Zhong F, Bi R, Yu B, Cheng Y, Xu X, Shui R, Yang W (2014) Carcinoma arising in microglandular adenosis of the breast: triple negative phenotype with variable morphology. Int J Clin Exp Pathol 7(9):6149–6156PubMedPubMedCentral
13.
Zurück zum Zitat Koenig C, Dadmanesh F, Bratthauer GL, Tavassoli FA (2000) Carcinoma arising in microglandular adenosis: an immunohistochemical analysis of 20 intraepithelial and invasive neoplasms. Int J Surg Pathol 8(4):303–315CrossRefPubMed Koenig C, Dadmanesh F, Bratthauer GL, Tavassoli FA (2000) Carcinoma arising in microglandular adenosis: an immunohistochemical analysis of 20 intraepithelial and invasive neoplasms. Int J Surg Pathol 8(4):303–315CrossRefPubMed
14.
Zurück zum Zitat Oka K, Sando N, Moriya T, Yatabe Y (2007) Malignant adenomyoepithelioma of the breast with matrix production may be compatible with one variant form of matrix-producing carcinoma: a case report. Pathol Res Pract 203(8):599–604. doi:10.1016/j.prp.2007.04.004 CrossRefPubMed Oka K, Sando N, Moriya T, Yatabe Y (2007) Malignant adenomyoepithelioma of the breast with matrix production may be compatible with one variant form of matrix-producing carcinoma: a case report. Pathol Res Pract 203(8):599–604. doi:10.​1016/​j.​prp.​2007.​04.​004 CrossRefPubMed
Metadaten
Titel
Breast carcinoma with a predominant duct-replacing component and chondroid matrix production
verfasst von
Shogo Tajima
Kenji Koda
Publikationsdatum
28.03.2015
Verlag
Springer Japan
Erschienen in
Medical Molecular Morphology / Ausgabe 4/2016
Print ISSN: 1860-1480
Elektronische ISSN: 1860-1499
DOI
https://doi.org/10.1007/s00795-015-0101-8

Weitere Artikel der Ausgabe 4/2016

Medical Molecular Morphology 4/2016 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …